Latest Peplin news



news 

01-Feb-10

LEO Pharma's PEP005 Meets Primary Endpoint in Phase III Trial for Pre-Cancerous Skin Condition read more

21-Dec-09

Positive Results for LEO Pharma's Phase III Actinic Keratosis Trials on the Face and Scalp read more

12-Nov-09

Letter to our CDI Holders read more


›› More News
click here to download the Adobe reader

ASX and media 2008 releases

Current year | 2008 | 2007 | Archived

Archived 2008

16-Dec-08 Peplin completes enrolment for its first Phase III AK clinical trial 23 Kb
02-Dec-08 Registration statement including financial report 1 Mb
02-Dec-08 Form 10-Q - Quarterly Report 292Kb
01-Dec-08 Peplin results for the quarter ended 30 September 2008 25 Kb
01-Dec-08 ATO class ruling 82 Kb
10-Nov-08 Peplin to present at the 2008 Rodman & Renshaw Healthcare Conference 576 Kb
04-Nov-08 Registration statement declared effective 104 Kb
03-Nov-08 Corporate Governance Statement 37 Kb
28-Oct-08 Amendment two to Form 10 registration statement 1 Mb
27-Oct-08 Peplin completes US$24m fundraising 25 Kb
20-Oct-08 Amendment one to Form 10 registration statement 1 Mb
20-Oct-08 Peplin's acquisition of Neosil complete 25 Kb
16-Oct-08 Peplin to present at 2008 Wilson HTM Investment Group Life Science Conference 156 Kb
06-Oct-08 Results of Annual General Meeting 19 Kb
06-Oct-08 2008 Annual Meeting of Stockholders Script 754 Kb
24-Sep-08 The dawn of a new era presentation 656 Kb
09-Sep-08 Peplin announces the commencement of its Phase III clinical trial for PEP005 Gel in AK 29 Kb
05-Sep-08 Chief Financial Officer succession 24 Kb
04-Sep-08 Peplin to present at the 2008 Thomas Weisel Partners Healthcare Conference 410 Kb
03-Sep-08 Chief Executive Officer employment agreement summary 34 Kb
03-Sep-08 Notice of Annual Meeting of Stockholders 656 Kb
29-Aug-08 Results for the financial year ended 30 June 2008 28 Kb
28-Aug-08 Peplin to present at the 2008 Thomas Weisel Partners Healthcare Conference 29 Kb
19-Aug-08 Peplin secures approximately US$24m in additional financing 30 Kb
19-Aug-08 Peplin announces Executive Management Appointments 33 Kb
14-Aug-08 Enrolment complete in Phase IIb AK clinical trial 28 Kb
31-Jul-08 Peplin to present at Summer American Academy of Dermatology Meeting 31 Kb
25-Jun-08 Start of Phase IIb AK clinical trial 28 Kb
24-Jun-08 Scheme of arrangement tax information update 18 Kb
20-Jun-08 Appointment of interim consultant CMO 25 Kb
11-Jun-08 Peplin Investor Call 1.1 Mb
10-Jun-08 Acquisition of Neosil 24 Kb
10-Jun-08 Peplin to start Phase III under SPA agreement with FDA 30 Kb
10-Jun-08 Withdrawal of S-1 24 Kb
29-Apr-08 Chief Medical Officer resignation 19 Kb
21-Apr-08 Results of Special Meeting of Stockholders 19 Kb
25-Mar-08 Notice of Special Meeting of Stockholders 40 Kb
16-Jan-08 Results of Special Meeting of Stockholders 23 Kb